P.0533 Paliperidone palmitate 6-month long-acting injectable for schizophrenia: A randomised, double-blind, multicenter, noninferiority phase 3 study
| Autor: | Najarian, D., Sanga, P., Wang, S., Lim, P., Singh, A., Robertson, M.J., Cohen, K., Schotte, A., Milz, R., Venkatasubramanian, R., T'Jollyn, H., Walling, D.P., Galderisi, S., Gopal, S. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology December 2021 53 Supplement 1:S393-S393 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect